Ye Xuying: Accumulate Experience and Innovate
Release time:
2023-03-21
In Jianfeng Health Technology Company, when it comes to people who know the production equipment best, most people think of Ye Xuying first.
Ye Xuying entered Peak Health in 2015 and has been the manager of the production department. He is mainly responsible for the production management of three workshops: health care products, Chinese herbal pieces and plant extraction. He said that he has been engaged in drug and extract related work since graduation, and has been in the production line for more than 20 years. No matter what type of production line, most of the equipment principles are similar, and he is very interested in mechanical equipment. As long as you look at the circuit diagram and know the principle of the equipment, you will basically understand the operating performance of the equipment. Therefore, in the production process, if there is a problem with the equipment, the operator will first find him to solve it. However, he has always advocated that workshop employees can carry out simple tasks such as equipment maintenance by themselves, because they can improve efficiency. Especially in the clean area, it takes a long time for the mechanic to clean and disinfect. If the employee can solve the small problem by himself, the downtime of the equipment can be greatly saved. When
Ye Xu Ying first entered the company, he found that the employees in the workshop were not familiar with the performance of the equipment. There were still some differences between the laboratory process and the production on the production line. Moreover, each employee's understanding and acceptance ability was different. Someone needed to convert the experimental process into the workshop production process and formulate the operation procedures to ensure the smooth production, reduce errors and ensure the product quality. So Ye Xuying, who had just entered the company, became the "bridge" and first improved the product technology in the workshop. In recent years, he has also trained five master operators who can master job operation skills.
The understanding of the equipment process also laid a solid foundation for Ye Xuying's technological innovation and technological transformation. peak health of the main products of rhodiola rosea broken ganoderma lucidum spore powder soft capsule (jingzhi cikang) main raw materials by rhodiola rosea, ganoderma lucidum spore powder, ginseng and other 6 kinds of chinese herbal medicine composition. In the process of pressing the soft capsule, the contents are bonded together after repeated friction and heat generation in the injection pump, resulting in the particle size of the material becoming larger to the level that does not meet the conditions to be met for pressing the soft capsule. When the rubber is pressed, it is easy to leak oil from gaps, thus the soft capsule cannot be pressed continuously, and even the whole batch of soft capsules is scrapped. This problem once restricted the production of Jingzhi Cikang. However, the contents of most soft capsules on the market are relatively single. As long as the fineness of the contents is ensured, the qualified rate of soft capsules will be very high. Because there is no ready-made reference experience, Ye Xuying began his exploration. He optimized the pressing parameters and content preparation process according to the properties of solid materials. He used the existing wall-breaking equipment in the workshop and adopted the wall-breaking crushing treatment method to successfully eliminate the risk of oil leakage of soft capsules, greatly improving the yield of finished products, and theoretically making the products easier to be absorbed by human body.
When it comes to these innovations and renovations, Ye Xuying is like a treasure. Before, a company that made dried blueberries found Spike Health to help decolorize the sugar water soaked in blueberries. During the chat, they said that they wanted to press tablets with blueberry extract to make tableted candy. However, due to the strict requirements on the content of proanthocyanidins, they could not add too many auxiliary materials, and several companies could not solve the technical problem of tableting. In the process of tablet compression, auxiliary materials need to be added for bonding. General adhesives are solid. The content of proanthocyanidins will be reduced if more is added, but the compression is not good if less is added. After learning about this situation, Ye Xuying's brain turned again, since the solid is not good, what about the liquid? The nature of blueberry extract is quite special, and it can dissolve with many kinds of organic solvents, so he started a round of attempts by using this characteristic. At present, it has successfully provided 3 pilot samples to the other party, and has reached the quality requirements of tablets in terms of appearance color, product content, hardness, etc. The preparation method also applied for an invention patent.
Ye Xuying said that his innovations and inventions are all derived from years of work experience and familiarity with equipment and technology. In recent years, he has applied for 6 patents, participated in a number of government projects, developed a number of new products, and was also rated as the 2022 "Outstanding Enterprise Science and Technology Talent" in Wucheng District ". In his heart, there is a good wish, that is, Peak Health can achieve breakthroughs with the joint efforts of everyone, use modern technology to accelerate the progress of digitization, build a digital chemical factory, and strengthen and grow the health industry. And he is working with his colleagues to contribute to this goal. (Ni Yingzhen Chen Shengmu)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11